Holen Sie sich die Stockscreener-App
2.26
0.44%
-0.01
Schlusskurs vom Vortag:
$2.27
Offen:
$2.29
24-Stunden-Volumen:
160.93K
Relative Volume:
0.64
Marktkapitalisierung:
$68.55M
Einnahmen:
$188.16M
Nettoeinkommen (Verlust:
$18.43M
KGV:
5.0222
EPS:
0.45
Netto-Cashflow:
$26.45M
1W Leistung:
-7.00%
1M Leistung:
+18.32%
6M Leistung:
-17.82%
1J Leistung:
-43.36%
1-Tages-Spanne:
$2.195
$2.335
1-Wochen-Bereich:
$2.12
$2.50
52-Wochen-Spanne:
$1.27
$4.7498
Biote Corp Stock (BTMD) Company Profile
Firmenname
Biote Corp
Sektor
Branche
Telefon
972-486-9346
Adresse
1875 W. WALNUT HILL LN #100, IRVING
Compare BTMD vs MOBBW, SHMD, GOODO, PSNYW, DWLD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BTMD
Biote Corp. Class A Common Stock
|
5.89 | 33.33M | 0 | 0 | 0 | 0.00 |
MOBBW
Mobilicom Limited Warrants
|
2.38 | 3.16B | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
6.54 | 425.01M | 52.15M | -21.46M | 0 | -0.4675 |
GOODO
Gladstone Commercial Corporation
|
20.26 | 372.90M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.909 | 269.09M | 2.07B | -1.42B | -1.37B | -0.6765 |
DWLD
Davis Select Worldwide ETF
|
46.61 | 0 | 0 | 0 | 0 | 0.00 |
Biote Corp Stock (BTMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-07 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2024-12-16 | Eingeleitet | Craig Hallum | Buy |
| 2024-02-20 | Eingeleitet | B. Riley Securities | Buy |
| 2024-02-01 | Eingeleitet | Jefferies | Buy |
| 2022-06-24 | Eingeleitet | Cowen | Outperform |
| 2022-06-23 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Biote Corp Aktie (BTMD) Neueste Nachrichten
Biote Corp (BTMD) Institutional Confidence - TradingKey
Biote Corp (BTMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Biote Corp (BTMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
Biote Corp (BTMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Biote Corp (BTMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Biote Corp (BTMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Biote Corp (BTMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Biote Corp (BTMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biote Corp (BTMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
biote (BTMD) details salary, bonus and equity for Interim CEO Peterson - Stock Titan
biote Corp. (BTMD) interim CEO receives 206,746 stock options at $2.46 strike - Stock Titan
Biote Corp. (BTMD) Q1 2026 Earnings: EPS Beats Estimates by 23.71%, Stock Edges HigherHigh Growth Earnings - newsline.com
biote Corp. (BTMD) director receives 130,000 stock options at $2.34 strike - Stock Titan
biote Corp. (BTMD) Executive Chairman receives 114,157 stock options at $2.34 - Stock Titan
Biote Corp. (BTMD) Holds Steady at $2.34: Consolidation or Calm Before the Next Move?Hot Stock Picks - newsline.com
Biote Corp. Q1 2026 Earnings: EPS Beat Drives Cautious Optimism Amidst Flat Revenue DisclosureLong-Term Guidance - newsline.com
How The Evolving Story For biote (BTMD) May Shape Future Investor Expectations - Yahoo Finance
Biote Corp. (BTMD) Slides Toward Key Support Level as Selling Pressure PersistsFactor Rotation - newsline.com
Biote Appoints Bob Peterson as Interim CEO, Reaffirms 2026 Financial Guidance Amid Leadership Transition - Minichart
Biote (NASDAQ: BTMD) names interim CEO, appoints Executive Chairman and reaffirms 2026 outlook - Stock Titan
Biote appoints Bajaj as Chief Medical Officer - TipRanks
Biote Corp. (BTMD) Q1 2026 Earnings: EPS Beat Drives 4.5% Stock UptickEBITDA Analysis - The Legal Advocate
Biote names Komal Bajaj as chief medical officer - Investing.com
Biote names Komal Bajaj as chief medical officer By Investing.com - Investing.com South Africa
NYC hospital quality chief Komal Bajaj becomes Biote CMO - Stock Titan
Biote Corp. Q1 2026 Earnings: EPS Beats Estimates but Stock Declines Amid Revenue Uncertainty - newsline.com
BTMD Q1 2026 Earnings: EPS Surprises by 23.7% Despite Negative Stock ReactionStrong Earnings Momentum - newsline.com
CEO out after year leading hormone therapy company Biote - The Business Journals
Bob Peterson Named Interim CEO of Biote Corp., Effective May 28, 2026 - geneonline.com
Biote Names Its Chief Financial and Business Officer as Interim CEO - Dallas Innovates
Biote names CFO Bob Peterson as interim CEO, reaffirms FY26 outlook amid leadership shift - MSN
Biote announces Christensen to step down as CEO, Peterson named interim CEO - TipRanks
Biote names Bob Peterson interim CEO as Christensen steps down - Investing.com UK
Biote Announces Management Changes - marketscreener.com
Biote Announces Chief Executive Officer Changes - marketscreener.com
Biote Reaffirms Earnings Guidance for the Full Year 2026 - marketscreener.com
Biote names Bob Peterson as interim CEO - marketscreener.com
Biote names Bob Peterson interim CEO as Christensen steps down By Investing.com - Investing.com Australia
Biote Board Retained Executive Search Firm to Assist With Identification, Evaluation of CFO Candidates >BTMD - Moomoo
Biote CEO steps down for family reasons as CFO Bob Peterson takes interim helm - Stock Titan
BTMD Q1 2026 Earnings: EPS Beats Estimates by 23.71% Amid Revenue DiscrepancyStrong Earnings Momentum - newsline.com
Number of shareholders of Biote Corp. – NASDAQ:BTMD - TradingView
Biote Corp. (BTMD) Declines 3.86%, Approaches Critical Support at $1.89Vanna Flow - newsline.com
Biote Corp. (BTMD) Extends Decline: Down 3.86% as Support Level Comes into FocusSpring Pattern - The Legal Advocate
BTMD Q1 2026 Earnings: Biote Corp. Beats EPS Estimates, Stock Declines SlightlyEarnings Call Highlights - Newser
biote shareholders elect directors and ratify Deloitte appointment - TipRanks
biote Corp. (NASDAQ: BTMD) investors back board nominees and Deloitte as 2026 auditor - Stock Titan
Biote maintains 2026 outlook above $190M revenue as it targets restoring Asteria supply by end of Q2 - MSN
BTMD SEC FilingsBiote 10-K, 10-Q, 8-K Forms - Stock Titan
biote Corp. (BTMD) director Andrew Heyer receives options and 35,259 deferred RSUs - Stock Titan
Dow Theory LettersBiote Corp.Class A common stock (Nasdaq:BTMD) Stock Quote - FinancialContent
Finanzdaten der Biote Corp-Aktie (BTMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.63%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):